Table 1.
Characteristic | Mean ± SD (range) | |
---|---|---|
PD patients, n = 80 | Healthy participants, n = 60 | |
Age, y | 68.5 ± 7.5 (49–81) | 66.9 ± 9.9 (52–83) |
Sex: no. of men/women | 40/40 | 30/30 |
Handedness: no. right/left | 78/2 | 56/4 |
MoCA score | 26.4 ± 2.1 (21–30) | |
Disease duration, y | 5.8 ± 3.3 (0–14) | |
Hoehn & Yahr stage on | 2.0 ± 0.7 (1–4) | |
Levodopa equivalent, mg/d | 624.3 ± 392 (60–1855) | |
PDQ‐39 score | 39.93 ± 22.2 (5.0–91.0) | |
CR task: Mean score | 8.6 ± 3.0 (2.5–15.5) | 14.2 ± 3.0 (6.5–22.5) |
Right | 8.9 ± 3.4 (1.0–17.5) | 14.9 ± 3.1 (6.5–22.5) |
Left | 8.2 ± 3.6 (2.5–16.0) | 13.8 ± 3.2 (5.4–22.0) |
DextQ‐24 score | 38.5 ± 10.1 (24–73) | |
MDS‐UPDRS scoresa | ||
Part I | 10.1 ± 5.2 (1–23) | |
Part II | 4.9 ± 2.6 (0–11) | |
Part III | 14.5 ± 5.5 (4–29) |
MDS‐UPDRS part II contains Items 2.4 through 2.7, and part III contains Items 3.3 through 3.6 and Items 3.15 through 3.18.
Abbreviations: SD, standard deviation: PD, Parkinson's disease; MoCA, Montreal Cognitive Assessment; on, on medication; PDQ, Parkinson's Disease Questionnaire 39; CR, coin rotation; DextQ‐24, Dexterity questionnaire 24; MDS‐UPDRS, Movement Disorder Society‐Unified Parkinson's Disease Rating Scale.